These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6253698)

  • 1. Experimental coxsackievirus B3 perimyocarditis in the right ventricle in BALB/c mice: a one-year follow-up study.
    Matsumori A; Kawai C; Sawada S; Yamamoto K
    Jpn Circ J; 1980 Oct; 44(10):842-7. PubMed ID: 6253698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coxsackie virus B3 perimyocarditis in BALB/c mice: experimental model of chronic perimyocarditis in the right ventricle.
    Matsumori A; Kawai C
    J Pathol; 1980 Jun; 131(2):97-106. PubMed ID: 6253611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual pathologic changes and 99mtechnetium pyrophosphate uptake following coxsackievirus B3 perimyocarditis in mice.
    Matsumori A; Kadota K; Kambara H; Kawai C
    Jpn Circ J; 1980 Oct; 44(10):838-41. PubMed ID: 6253697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m pyrophosphate uptake in experimental viral perimyocarditis. Sequential study of myocardial uptake and pathologic correlates.
    Matsumori A; Kadota K; Kawai C
    Circulation; 1980 Apr; 61(4):802-7. PubMed ID: 6244121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocarditis in mice infected with Coxsackie virus B3.
    Hashimoto I
    Br J Exp Pathol; 1986 Oct; 67(5):737-45. PubMed ID: 3024693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
    Zhang H; Yousef GE; Ouyang X; Archard LC
    Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage.
    Chow LH; Gauntt CJ; McManus BM
    Lab Invest; 1991 Jan; 64(1):55-64. PubMed ID: 1990209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of viral RNA in experimental coxsackievirus B3 myocarditis of mice using the polymerase chain reaction.
    Okada I; Matsumori A; Kyu B
    Int J Exp Pathol; 1992 Dec; 73(6):721-31. PubMed ID: 1337265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalomyocarditis (EMC) virus myocarditis in DBA/2 mice. I. Acute stage.
    Matsumori A; Kawai C; Sawada S
    Jpn Circ J; 1981 Dec; 45(12):1403-8. PubMed ID: 6275136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successive infection of coxsackievirus B3 and encephalomyocarditis virus: an animal model of chronic myocarditis.
    Okada I; Matsumori A; Tomioka N; Kawai C
    J Pathol; 1992 Jul; 167(3):341-7. PubMed ID: 1325552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice.
    Matsumori A; Tomioka N; Kawai C
    Am Heart J; 1988 Jun; 115(6):1229-32. PubMed ID: 2837073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological mechanisms in experimental coxsackievirus B3 myocarditis in mice.
    Kishimoto C; Ochiai H; Sasayama S
    Jpn Circ J; 1991 Nov; 55(11):1144-8. PubMed ID: 1721094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix remodelling after coxsackievirus B3-induced murine myocarditis.
    Gómez RM; Castagnino CG; Berría MI
    Int J Exp Pathol; 1992 Oct; 73(5):643-53. PubMed ID: 1329915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
    Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
    Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
    Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial weight and virus dose: two factors affecting the onset of acute coxsackievirus B3 myocarditis in C57BL/6 mouse--a histopathology-based study.
    Li M; Wang X; Xie Y; Xie Y; Zhang X; Zou Y; Ge J; Chen R
    Cardiovasc Pathol; 2013; 22(1):96-101. PubMed ID: 22784985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of granulocyte colony-stimulating factor upon coxsackievirus B3 myocarditis in mice.
    Hiraoka Y; Kishimoto C; Takada H; Suzaki N; Shiraki K
    Eur Heart J; 1995 Dec; 16(12):1900-6. PubMed ID: 8682024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Coxsackie virus B-3 and B-4 myocarditis in mice.
    Kawai C; Matsumori A; Kumagai N; Tokuda M
    Jpn Circ J; 1978 Jan; 42(1):43-7. PubMed ID: 633597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of T lymphocytes in the pathogenesis of Coxsackie virus B3 heart disease.
    Hashimoto I; Tatsumi M; Nakagawa M
    Br J Exp Pathol; 1983 Oct; 64(5):497-504. PubMed ID: 6315043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal changes in stem cells in the circulation and myocardium of mice with Coxsackie virus B3-induced myocarditis.
    Zhao L; Li S; Ge J; Sun A; Zou Y; Zhang S
    Microvasc Res; 2008 Apr; 75(3):358-66. PubMed ID: 18206181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.